Figure 1.
Prevalence and distribution of standardised molecular Minimal Residual Disease (MRD) targets in adults >65 years entering the National Cancer Research Institute (NCRI) Acute Myeloid Leukemia (AML)-16 trial [47].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.